The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis

Nature

Volumn 498, Issue 7454, 2013, Pages 318-324

  Rivkin, Elena ^a,b   Almeida, Stephanie M ^a,b   Ceccarelli, Derek F ^a   Juang, Yu Chi ^a   MacLean, Teresa A ^a,b   Srikumar, Tharan ^b   Huang, Hao ^a   Dunham, Wade H ^a,b   Fukumura, Ryutaro ^c   Xie, Gang ^a   Gondo, Yoichi ^c   Raught, Brian ^b   Gingras, Anne Claude ^a,b   Sicheri, Frank ^a,b   Cordes, Sabine P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c RIKEN BIORESOURCE CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DISHEVELED 2 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; WNT PROTEIN;

CRYSTAL STRUCTURE; EMBRYO; GENE EXPRESSION; PHENOTYPE; SIGNALING; SUBSTRATE; TUMOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CRYSTAL STRUCTURE; EMBRYO DEVELOPMENT; GENE; GENE MUTATION; GUMBY GENE; MOUSE; MOUSE MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; UBIQUITINATION; WNT SIGNALING PATHWAY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALLELES; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CRYSTALLOGRAPHY, X-RAY; EMBRYO, MAMMALIAN; ENDOPEPTIDASES; FEMALE; GENE EXPRESSION PROFILING; HEK293 CELLS; HUMANS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; PHOSPHOPROTEINS; PROTEIN CONFORMATION; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION; WNT SIGNALING PATHWAY;

MUS;

EID: 84879390723     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature12296     Document Type: Article

References (49)

1. Risau, W. Mechanisms of angiogenesis. Nature 386, 671-674 (1997).
2. Logan, C. Y. & Nusse, R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20, 781-810 (2004).
3. Liebner, S. & Plate, K. H. Differentiation of the brain vasculature: the answer came blowing by the Wnt. J. Angio. Res. 2, 1 (2010).
4. Zerlin, M., Julius, M. A. & Kitajewski, J. Wnt/Frizzled signaling in angiogenesis. Angiogenesis 11, 63-69 (2008).
5. Daneman, R. et al. Wnt/b-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc. Natl Acad. Sci. USA 106, 641-646 (2009).
6. Stenman, J. M. et al. Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science 322, 1247-1250 (2008).
7. Cirone, P. et al.Arole for planar cell polarity signaling in angiogenesis. Angiogenesis 11, 347-360 (2008).
8. Wharton, K. A. Jr. Runnin' with the Dvl: proteins that associate with Dsh/Dvl and their significance to Wnt signal transduction. Dev. Biol. 253, 1-17 (2003).
9. Kirisako, T. et al. A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 25, 4877-4887 (2006).
10. Behrends, C. & Harper, J. W. Constructing and decoding unconventional ubiquitin chains. Nature Struct. Mol. Biol. 18, 520-528 (2011).
11. Walczak, H., Iwai, K. & Dikic, I. Generation and physiological roles of linear ubiquitin chains. BMC Biol. 10, 23 (2012).
12. Iwai, K. Linear polyubiquitin chains: a new modifier involved in NFkB activation andchronic inflammation, including dermatitis. Cell Cycle10,3095-3104(2011).
13. Gerlach, B. et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591-596 (2011).
14. Ikeda, F. et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-kB activity and apoptosis. Nature 471, 637-641 (2011).
15. Tokunaga, F. et al. SHARPIN is a component of the NF-kB-activating linear ubiquitin chain assembly complex. Nature 471, 633-636 (2011).
16. Niu, J., Shi, Y., Iwai, K. & Wu, Z. H.LUBACregulatesNF-kB activation upon genotoxic stress by promoting linear ubiquitination of NEMO. EMBO J. 30, 3741-3753 (2011).
17. Nijman, S. M. et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 123, 773-786 (2005).
18. Mar, L., Rivkin, E., Kim, D. Y., Yu, J. Y. & Cordes, S. P. A genetic screen for mutations that affect cranial nerve development in themouse. J. Neurosci.25, 11787-11795 (2005).
19. Hogan, K. A., Ambler, C. A., Chapman, D. L. & Bautch, V. L. The neural tube patterns vessels developmentally using the VEGF signaling pathway. Development 131, 1503-1513 (2004).
20. Gondo, Y. Trends in large-scale mouse mutagenesis: from genetics to functional genomics. Nature Rev. Genet. 9, 803-810 (2008).
21. Roca, C.& Adams, R. H. Regulation of vascularmorphogenesis by Notch signaling. Genes Dev. 21, 2511-2524 (2007).
22. Edelmann, M. J. et al. Structural basis and specificity of human otubain 1-mediated deubiquitination. Biochem. J. 418, 379-390 (2009).
23. Juang, Y. C. et al.OTUB1co-opts Lys48-linkedubiquitinrecognitionto suppressE2 enzyme function. Mol. Cell 45, 384-397 (2012).
24. Wiener, R., Zhang, X., Wang, T. & Wolberger, C. The mechanism of OTUB1-mediated inhibition of ubiquitination. Nature 483, 618-622 (2012).
25. Wang, T. et al. Evidence for bidentate substrate binding as the basis for the K48 linkage specificity of otubain 1. J. Mol. Biol. 386, 1011-1023 (2009).
26. Matsumoto, M. L. et al. Engineering and structural characterization of a linear polyubiquitin-specific antibody. J. Mol. Biol. 418, 134-144 (2012).
27. Rual, J. F. et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 437, 1173-1178 (2005).
28. Maretto, S. et al. Mapping Wnt/b-catenin signaling during mouse development and in colorectal tumors. Proc. Natl Acad. Sci. USA 100, 3299-3304 (2003).
29. HogenEsch, H. et al. A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice. Am. J. Pathol. 143, 972-982 (1993).
30. Seymour, R. E. et al. Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis. Genes Immun. 8, 416-421 (2007).
31. Rahighi, S. et al. Specific recognition of linear ubiquitin chains by NEMO is important for NF-kB activation. Cell 136, 1098-1109 (2009).
32. Mainardi, P. C. et al. The natural history of Cri du Chat Syndrome. A report fromthe Italian Register. Eur. J. Med. Genet. 49, 363-383 (2006).
33. Mainardi, P. C. et al. Clinical andmolecular characterisation of 80 patients with 5p deletion: genotype-phenotype correlation. J. Med. Genet. 38, 151-158 (2001).
34. Zhang, X. et al. High-resolution mapping of genotype-phenotype relationships in cri du chat syndrome using array comparative genomic hybridization. Am. J. Hum. Genet. 76, 312-326 (2005).
35. Ye, S., Dhillon, S., Ke, X., Collins, A. R. & Day, I. N. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res. 29, e88 (2001).
36. Adams, D. J. et al. A genome-wide, end-sequenced 129Sv BAC library resource for targeting vector construction. Genomics 86, 753-758 (2005).
37. DasGupta, R. & Fuchs, E. Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development 126, 4557-4568 (1999).
38. Ambulos, N. P. Jr, Duvall, E. J. & Lovett, P. S. Method for blot-hybridization analysis of mRNA molecules from Bacillus subtilis. Gene 51, 281-286 (1987).
39. Kim, F. A. et al. The vHNF1 homeodomain protein establishes early rhombomere identity by direct regulation of Kreisler expression. Mech. Dev. 122, 1300-1309 (2005).
40. Vecchi, A. et al.Monoclonal antibodies specific for endothelial cells ofmouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur. J. Cell Biol. 63, 247-254 (1994).
41. Abramoff, M. D., Magalhaes, P. J. & Ram, S. J. Image Processing with ImageJ. Biophotonics Intl 11, 36-42 (2004).
42. Torban, E., Wang, H. J., Groulx, N. & Gros, P. Independent mutations in mouse Vangl2 that cause neural tube defects in looptail mice impair interaction with members of the Dishevelled family. J. Biol. Chem. 279, 52703-52713 (2004).
43. Veeman, M. T., Axelrod, J. D. & Moon, R. T. A second canon. Functions and mechanisms of b-catenin-independent Wnt signaling. Dev. Cell 5, 367-377 (2003).
44. Ernst, A. et al. A strategy for modulation of enzymes in the ubiquitin system. Science 339, 590-595 (2013).
45. Kean, M. J., Couzens, A. L. & Gingras, A. C. Mass spectrometry approaches to study mammalian kinase and phosphatase associated proteins. Methods 57, 400-408 (2012).
46. Dunham, W. H. et al. A cost-benefit analysis ofmultidimensional fractionation of affinitypurification-mass spectrometry samples. Proteomics11,2603-2612(2011).
47. Liu, G. et al. ProHits: integrated software for mass spectrometry-based interaction proteomics. Nature Biotechnol. 28, 1015-1017 (2010).
48. Choi, H. et al. Analyzing protein-protein interactions fromaffinitypurification-mass spectrometry data with SAINT. Curr. Protoc. Bioinform. Ch. 8, Unit 8.15 (2012).
49. Choi, H. et al. SAINT: probabilistic scoring of affinity purification-mass spectrometry data. Nature Methods 8, 70-73 (2011).